Unfractionated heparin
Seki, Y.
Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 142-146
2011
ISSN/ISBN: 0047-1860 PMID: 21761763 Document Number: 653009
Document emailed within 1 workday
Related Documents
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Merton, R.E.; Thomas, D.P.; Havercroft, S.J.; Barrowcliffe, T.W.; Lindahl, U. 1984: High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs Thrombosis and Haemostasis 51(2): 254-256
Jacobs, C.; Grebe, S.; Kietzmann, M.; Mischke, R. 1999: Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity Deutsche Tierärztliche Wochenschrift 106(11): 478-481
Chigot, P.; De Gennes, C.; Samama, M.M. 1996: Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin Journal des Maladies Vasculaires 21(3): 121-125
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Lassila, R.; Leinonen, H. 2001: Is unfractionated heparin still needed? Duodecim; Laaketieteellinen Aikakauskirja 117(24): 2597-2599
Ridgway, P.F.; Crosbie, J.; Hinedi, K.A.; Ghadban, W.; Kelly, A.; O'Donnell, R.; Hollingsworth, J. 1999: Unfractionated heparin, time for a change? Irish Medical Journal 92(3): 302-306
Spinler, S.A. 1998: Unfractionated heparin dosing in the FRIC study Circulation 97(14): 1424
Meyer, G. 2015: Is there still a place for unfractionated heparin in venous thromboembolism? La Revue du Praticien 65(2): 199
Ghali, W.A.; Pannatier, A.; Tsuyuki, R.T.; Hull, R.D.; MacKay, E.; Quan, H.; Cornuz, J. 2002: Transition from unfractionated heparin to low molecular weight heparins Thrombosis and Haemostasis 88(3): 539-540
Paglia, I.; Carrieri, L.; Oliaro, E.; Bergerone, S.; Mangiardi, L.; Trevi, G.P. 2002: A case of pulmonary thromboembolism after interruption of treatment with unfractionated heparin Minerva Cardioangiologica 50(4): 379-382
Shammas, N.W.; Lemke, J.H.; Dippel, E.J.; McKinney, D.E.; Takes, V.S.; Youngblut, M.; Harris, M.; Harb, C.; Kapalis, M.J.; Holden, J. 2003: In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant Journal of Invasive Cardiology 15(5): 242-246
Bernardi, E.; Piccioli, A.; Oliboni, G.; Zuin, R.; Girolami, A.; Prandoni, P. 2000: Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview Thrombosis and Haemostasis 84(1): 22-26
Brunkwall, J.; Mätzsch, T.; Bergqvist, D. 1990: The effect of unfractionated and low-molecular-weight heparin on the release of prostacyclin from the arterial wall Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 641-645
Iorio, A.; Agnelli, G. 2000: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis Archives of Internal Medicine 160(15): 2327-2332
Chen, J-lin.; Chen, J.; Qiao, S-bin.; Guo, Y-lin.; Wu, Y-jian.; Dai, J.; Yuan, J-qing.; Qin, X-wen.; Yang, Y-jin.; Gao, R-lin. 2006: A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease Chinese Medical Journal 119(5): 355-359
Patel, A.A.; White, C.M.; Coleman, C.I. 2007: Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention Connecticut Medicine 71(2): 93-95
Li, J.; Liu, Z.; Zhang, S.; Shen, Z.; Fan, Z.; Zeng, Y.; Xie, H.; Wang, C.; Jin, X.; Fang, Q.; Zhu, W. 2015: Activated clotting time post therapeutic anticoagulation with unfractionated heparin in patients undergoing elective percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 43(5): 408-412
Arsanjani, R.; Khitri, A.; Hashemzadeh, M.; Movahed, M.R. 2012: Low-dose unfractionated heparin administration during intravascular ultrasound studies is safe even shortly after endomyocardial biopsy in cardiac transplant patients Journal of Invasive Cardiology 24(4): 154-156